Formulary Search

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

No local trust is a NHSE commissioned specialist cardiac centre

1st month supply from specialist team before request for primary care prescribing

1st month supply from specialist team before request for primary care prescribing

Off-label use. Hot flushes caused by long-term androgen suppression in men with prostate cancer

1st month supply from specialist team before request for primary care prescribing

Off-label use. On recommendation of palliative care team.

1st month supply from specialist team before request for primary care prescribing

DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically.  Circadin is NON-FORMULARY

DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)

If immediate onset of action is required or crushed to aid swallowing

DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)

All formulations of melatonin for adults under 55 without neurodevelopmental disorders were agreed by APC as NON-FORMULARY

DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)

Not a cost effective option

Rapid eye movement  sleep behaviour disorder. (RBD)

On specialist recommendation

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically.  Circadin is NON-FORMULARY

Rapid eye movement  sleep behaviour disorder. (RBD)

If immediate onset of action is required or crushed to aid swallowing

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.

Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).

Not a cost-effective option. Prescribe as separate components.

Sitagliptin is the preferred DPP4. Reserve combination products for patients in whom separate components are less appropriate. Existing patients would not be expected to change therapy unless appropriate to do so.

Option for non-scarring alopecia